EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Is a
Allocation Type
Randomized
0
Trial Collaborator
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Interventional Trial Phase
Phase 2
0
Interventional Trial Purpose
Treatment
0
Intervention Treatment
Rifabutin
0
Intervention Type
Drug
0
Last Updated
August 13, 2012
0
Masking Type
None (Open Label)
0
Primary Completion Date
2014
0
Trial Recruitment Size
140
0
Clinical Trial Start Date
2011
0
Study Completion Date
2014
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Toxicity and Pharmacokinetics of Different Rifabutin Doses in HIV-infected Adults and Adolescents Taking Lopinavir / Ritonavir as Second-line Anti-retroviral Therapy (ART) (EARNEST Rifabutin PK Substudy)
0
Official Website
Find more entities like EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.